infowebsite.in
Stocks to watch today: The shares of NCC, Bajaj Auto, Cipla, Sun Pharmaceutical Industries, Azad Engineering and other companies are trending on November 4, 2024.
Trending Stocks today: Azad Engineering, NCC, Bajaj Auto and more (Pic: Depositphotos)
Mumbai: The share price of Azad Engineering, NCC, Bajaj Auto, Cipla and Sun Pharmaceutical Industries Ltd and other companies are in focus on November 4, 2024 (Monday). The BSE Sensex, and Nifty plunged in early trade today dragged by Reliance Industries.
Azad Engineering share price
Azad Engineering share price jumped over 13 per cent to Rs 1,652.65 in early trade today. Azad Engineering shares jumped as the company signed a deal with Mitsubishi Heavy Industries Limited to supply advanced rotating and stationary airfoils for gas and thermal power turbine engines.
NCC share price
NCC share price in green in the early morning at Rs 313.70. The stock is in news after it confirmed to the exchanges that it has received Rs 3,496 crore order in October. Ace stock market investor Rekha Jhunjhunwala is a stakeholder in NCC.
Bajaj Auto share price
Bajaj Auto share price dropped to Rs 9,451.20 today morning. The stock fell after the company reported that its total sales rose 1.7 percent year-on-year at 4.79 lakh units in October 2024, as against 4.71 lakh units in October 2023. In the domestic commercial vehicles segment, the automaker reported a decline of 6 percent year-on-year in October 2024, however, it mentioned that the exports jumped by 46 percent last month. In the domestic two-wheelers segment, the company registered a drop of 8 percent year-on-year in October 2024 whereas exports during the month increased 22 percent.
Cipla share price
Cipla share price in green territory at Rs 1,576.10. Brokerage firm Nuvama Institutional Equities maintained a ‘HOLD’ strategy with a target price of Rs 1,601. Earlier, it had set the target price at Rs 1,593.
Sun Pharmaceutical Industries Ltd
Sun Pharmaceutical share price slumped over 3 percent to Rs 1,801.95. The stock slumped after a US District Court of New Jersey ruled that a preliminary injunction in a patent dispute case against the drugmaker’s hair loss drug, Leqselvi.
Next Article
Follow us on social media
